EMERYVILLE, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

The omission of Rob Reiner &Michele Reiner from the Gray Lady's The Lives They Lived end of year list was all a matter of ...

NCIS: Tony & Ziva picks up after Ziva’s supposed death when Tony left the NCIS team to go raise their daughter. Years later, ...

According to DataM Intelligence, the global cell and gene therapy market reached a value of US$13.90 billion in 2024 and is ...

Hackers have exposed heavily redacted information from the latest 11,034 documents in the Epstein files, released on Monday.

Mac Security Bite is exclusively brought to you by Mosyle, the only Apple Unified Platform. Making Apple devices work-ready and ...

As Gartner Predicts Vector Databases Will Be Used in 30% of Enterprise Applications by 2026, Milvus Reaches Major Milestone ...

Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...

The collaboration will co-innovate to deliver AI-powered solutions, combining Microsoft's trusted cloud with Cognizant's ...